M
Milestone Pharmaceuticals D
D
MIST
1.70000
USD
-0.03
(-1.73%)
مغلق
حجم التداول
3,156
الربح لكل سهم
-1
العائد الربحي
-
P/E
-2
حجم السوق
90,889,264
العنوان: Milestone Pharmaceuticals
القطاع: Healthcare
الصناعة: Biotechnology
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal sprayto be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).